Phenotyping Cardiogenic Shock.
cardiogenic shock
clusters
heart failure
hemodynamics
machine learning
myocardial infarction
phenotypes
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
20 07 2021
20 07 2021
Historique:
pubmed:
7
7
2021
medline:
30
10
2021
entrez:
6
7
2021
Statut:
ppublish
Résumé
Background Cardiogenic shock (CS) is a heterogeneous syndrome with varied presentations and outcomes. We used a machine learning approach to test the hypothesis that patients with CS have distinct phenotypes at presentation, which are associated with unique clinical profiles and in-hospital mortality. Methods and Results We analyzed data from 1959 patients with CS from 2 international cohorts: CSWG (Cardiogenic Shock Working Group Registry) (myocardial infarction [CSWG-MI; n=410] and acute-on-chronic heart failure [CSWG-HF; n=480]) and the DRR (Danish Retroshock MI Registry) (n=1069). Clusters of patients with CS were identified in CSWG-MI using the consensus k means algorithm and subsequently validated in CSWG-HF and DRR. Patients in each phenotype were further categorized by their Society of Cardiovascular Angiography and Interventions staging. The machine learning algorithms revealed 3 distinct clusters in CS: "non-congested (I)", "cardiorenal (II)," and "cardiometabolic (III)" shock. Among the 3 cohorts (CSWG-MI versus DDR versus CSWG-HF), in-hospital mortality was 21% versus 28% versus 10%, 45% versus 40% versus 32%, and 55% versus 56% versus 52% for clusters I, II, and III, respectively. The "cardiometabolic shock" cluster had the highest risk of developing stage D or E shock as well as in-hospital mortality among the phenotypes, regardless of cause. Despite baseline differences, each cluster showed reproducible demographic, metabolic, and hemodynamic profiles across the 3 cohorts. Conclusions Using machine learning, we identified and validated 3 distinct CS phenotypes, with specific and reproducible associations with mortality. These phenotypes may allow for targeted patient enrollment in clinical trials and foster development of tailored treatment strategies in subsets of patients with CS.
Identifiants
pubmed: 34227396
doi: 10.1161/JAHA.120.020085
pmc: PMC8483502
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e020085Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL139785
Pays : United States
Références
Eur Heart J. 2017 Dec 14;38(47):3523-3531
pubmed: 29020341
Circ Cardiovasc Qual Outcomes. 2016 Mar;9(2):117-25
pubmed: 26884615
Eur J Heart Fail. 2015 May;17(5):501-9
pubmed: 25820680
Bioinformatics. 2010 Jun 15;26(12):1572-3
pubmed: 20427518
Eur Heart J. 2014 Jan;35(3):156-67
pubmed: 24014384
Lancet Diabetes Endocrinol. 2019 Sep;7(9):684-694
pubmed: 31345776
Eur J Heart Fail. 2019 Nov;21(11):1370-1378
pubmed: 31339222
IEEE Trans Pattern Anal Mach Intell. 1979 Mar;1(3):306-7
pubmed: 21868861
J Am Coll Cardiol. 2017 Apr 18;69(15):1913-1920
pubmed: 28408020
JAMA. 2019 May 28;321(20):2003-2017
pubmed: 31104070
J Heart Lung Transplant. 2009 Jun;28(6):535-41
pubmed: 19481012
Circulation. 2018 Nov 13;138(20):2298-2300
pubmed: 30571518
J Am Coll Cardiol. 2019 Oct 29;74(17):2129-2131
pubmed: 31548098
Circulation. 2015 Jan 20;131(3):232-3
pubmed: 25601948
Circulation. 2015 Jan 20;131(3):269-79
pubmed: 25398313
Catheter Cardiovasc Interv. 2019 Jul 1;94(1):29-37
pubmed: 31104355
N Engl J Med. 1999 Aug 26;341(9):625-34
pubmed: 10460813
Am J Epidemiol. 2014 Mar 15;179(6):764-74
pubmed: 24589914
Bioinformatics. 2012 Jan 1;28(1):112-8
pubmed: 22039212
Eur Heart J. 2019 Aug 21;40(32):2671-2683
pubmed: 31274157
Am J Cardiol. 1967 Oct;20(4):457-64
pubmed: 6059183
Circulation. 2017 Oct 17;136(16):e232-e268
pubmed: 28923988
Circ Heart Fail. 2020 Sep;13(9):e007099
pubmed: 32900234
N Engl J Med. 1979 Jun 14;300(24):1350-8
pubmed: 440357
Lancet Diabetes Endocrinol. 2018 May;6(5):361-369
pubmed: 29503172
J Am Coll Cardiol. 2019 Oct 29;74(17):2117-2128
pubmed: 31548097
J Am Heart Assoc. 2014 Jan 13;3(1):e000590
pubmed: 24419737